Literature DB >> 2754427

Clearance of hepatitis B virus DNA and pre-S surface antigens in patients with markers of acute viral replication.

C Delfini1, S Colloca, G Taliani, F Mazzotta, A D'Agata, C Buonamici, T Stroffolini, G Carloni.   

Abstract

To clarify the relationship between the pre-S antigens and other serological markers of hepatitis B virus (HBV) replication, we followed up 27 patients: 21 presented with symptoms of acute hepatitis (two progressed to chronicity) and six suffered from chronic hepatitis. Pre-S1, pre-S2, HBV DNA, IgM antihepatitis core antigen (HBc), hepatitis B e antigen (HBeAg), and anti-HBe were detected in about 200 sera serially collected at different times for at least 6-12 months from the onset of clinical observation. In the early symptomatic phase of acute hepatitis, the pre-S1 and pre-S2 antigens were present in 95% of the cases and correlated well with high levels of alanine-transferase (ALT) and IgM anti-HBc, while HBV DNA was present in the sera of only six (28.6%) patients (P less than 0.0001). This was the first marker to disappear (1 month after the initial stage). All of the HBV DNA-positive patients were also HBeAg positive, whereas no HBeAg-negative subjects were found with serum HBV DNA. In the six chronic patients, pre-S antigens were always present independently of the HBeAg/anti-HBe status; HBV DNA was detected in three of them, even if transiently, and in two of these it reappeared together with pre-S2 epitope. The follow-up data suggest that, in acute hepatitis, the clearance of pre-S antigens can be considered as a prognostic index of clinical resolution and that, in chronic hepatitis, the persistence of pre-S antigens seems to indicate progression of the disease. In particular, pre-S2, in patients in whom it is intermittent, can be considered as an index of reactivation.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2754427     DOI: 10.1002/jmv.1890280312

Source DB:  PubMed          Journal:  J Med Virol        ISSN: 0146-6615            Impact factor:   2.327


  3 in total

1.  Establishment and preliminery use of hepatitis B virus preS1/2 antigen assay.

Authors:  Kun Chen; Bao-Guang Han; Xian-Kai Ma; He-Qiu Zhang; Li Meng; Guo-Hua Wang; Fang Xia; Xiao-Guo Song; Shi-Gan Ling
Journal:  World J Gastroenterol       Date:  1999-12       Impact factor: 5.742

2.  Comparison of pre-S1 and pre-S2 proteins in hepatocytes with replication by in situ hybridization assay.

Authors:  Y Y Zhang; Z Q Yu; Y K Wan; P Yan; L J Hao
Journal:  J Tongji Med Univ       Date:  1990

3.  Correlation of preS antigens and clinical status during chronic hepatitis B virus infection.

Authors:  G Taliani; M Rapicetta; D Francisci; J Xiang; B Sarrecchia; C De Bac; G Stagni
Journal:  Med Microbiol Immunol       Date:  1991       Impact factor: 3.402

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.